Legal & General Group PLC Biogen Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Biogen Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 1,511,506 shares of BIIB stock, worth $239 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,511,506
Previous 1,511,506 -0.0%
Holding current value
$239 Million
Previous $293 Million -0.0%
% of portfolio
0.06%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$189.07 - $236.8 $7.05 Million - $8.83 Million
-37,307 Reduced 2.41%
1,511,506 $293 Million
Q2 2024

Aug 14, 2024
SELL
$190.52 - $236.72 $385,993 - $479,594
-2,026 Reduced 0.13%
1,548,813 $359 Million
Q1 2024

May 14, 2024
SELL
$212.02 - $267.71 $3.58 Million - $4.53 Million
-16,905 Reduced 1.08%
1,550,839 $334 Million
Q4 2023

Feb 15, 2024
BUY
$222.59 - $267.94 $50.9 Million - $61.3 Million
228,666 Added 17.08%
1,567,744 $406 Million
Q3 2023

Nov 14, 2023
SELL
$253.3 - $285.89 $7.71 Million - $8.7 Million
-30,443 Reduced 2.22%
1,339,078 $344 Million
Q2 2023

Aug 14, 2023
BUY
$275.25 - $318.06 $3.02 Million - $3.49 Million
10,974 Added 0.81%
1,369,521 $390 Million
Q1 2023

May 15, 2023
SELL
$256.56 - $292.34 $5.67 Million - $6.46 Million
-22,112 Reduced 1.6%
1,358,547 $378 Million
Q4 2022

Feb 14, 2023
SELL
$252.44 - $306.72 $12.3 Million - $15 Million
-48,840 Reduced 3.42%
1,380,659 $382 Million
Q3 2022

Nov 14, 2022
SELL
$194.69 - $268.46 $5.15 Million - $7.11 Million
-26,471 Reduced 1.82%
1,429,499 $382 Million
Q2 2022

Aug 22, 2022
BUY
$187.54 - $223.02 $2.93 Million - $3.48 Million
15,609 Added 1.08%
1,455,970 $297 Million
Q1 2022

May 16, 2022
BUY
$193.77 - $244.14 $15.9 Million - $20.1 Million
82,281 Added 6.06%
1,440,361 $303 Million
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $10.8 Million - $13.8 Million
-48,116 Reduced 3.42%
1,358,080 $326 Million
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $5.8 Million - $7.57 Million
20,504 Added 1.48%
1,406,196 $398 Million
Q2 2021

Aug 12, 2021
BUY
$259.0 - $414.71 $49.1 Million - $78.7 Million
189,746 Added 15.87%
1,385,692 $480 Million
Q1 2021

May 17, 2021
SELL
$242.95 - $284.63 $8.39 Million - $9.83 Million
-34,528 Reduced 2.81%
1,195,946 $335 Million
Q4 2020

Feb 12, 2021
SELL
$236.26 - $355.63 $10.6 Million - $15.9 Million
-44,714 Reduced 3.51%
1,230,474 $301 Million
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $9.33 Million - $10.8 Million
-35,245 Reduced 2.69%
1,275,188 $362 Million
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $12.9 Million - $17.1 Million
49,950 Added 3.96%
1,310,433 $351 Million
Q1 2020

May 14, 2020
BUY
$268.85 - $341.04 $1.36 Million - $1.73 Million
5,075 Added 0.4%
1,260,483 $399 Million
Q4 2019

Feb 13, 2020
BUY
$220.06 - $304.07 $3.46 Million - $4.78 Million
15,724 Added 1.27%
1,255,408 $373 Million
Q3 2019

Nov 13, 2019
BUY
$217.44 - $243.88 $3.7 Million - $4.15 Million
17,002 Added 1.39%
1,239,684 $289 Million
Q2 2019

Aug 14, 2019
SELL
$219.29 - $241.72 $1.73 Million - $1.91 Million
-7,884 Reduced 0.64%
1,222,682 $286 Million
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $48.9 Million - $76.4 Million
225,455 Added 22.43%
1,230,566 $291 Million
Q4 2018

Feb 15, 2019
BUY
$278.5 - $352.75 $15.4 Million - $19.5 Million
55,176 Added 5.81%
1,005,111 $302 Million
Q3 2018

Nov 20, 2018
SELL
$293.51 - $383.83 $6.53 Million - $8.54 Million
-22,260 Reduced 2.29%
949,935 $336 Million
Q2 2018

Aug 10, 2018
SELL
$257.52 - $306.91 $12.7 Million - $15.1 Million
-49,251 Reduced 4.82%
972,195 $282 Million
Q1 2018

May 17, 2018
SELL
$260.13 - $367.91 $10.8 Million - $15.3 Million
-41,690 Reduced 3.92%
1,021,446 $280 Million
Q4 2017

Feb 13, 2018
BUY
$307.64 - $344.58 $327 Million - $366 Million
1,063,136
1,063,136 $339 Million

Others Institutions Holding BIIB

# of Institutions
1,036
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email